Mehdi Rambod1, Janos Porszasz1, Barry J Make2, James D Crapo2, Richard Casaburi3. 1. Rehabilitation Clinical Trials Center, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA. 2. National Jewish Health, Denver, CO. 3. Rehabilitation Clinical Trials Center, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA. Electronic address: casaburi@ucla.edu.
Abstract
BACKGROUND: Exercise tolerance in COPD is only moderately well predicted by airflow obstruction assessed by FEV(1). We determined whether other phenotypic characteristics, including CT scan measures, are independent predictors of 6-min walk distance (6MWD) in the COPDGene cohort. METHODS: COPDGene recruits non-Hispanic Caucasian and African American current and ex-smokers. Phenotyping measures include postbronchodilator FEV(1) % predicted and inspiratory and expiratory CT lung scans. We defined % emphysema as the percentage of lung voxels < -950 Hounsfield units on the inspiratory scan and % gas trapping as the percentage of lung voxels < -856 Hounsfield units on the expiratory scan. RESULTS: Data of the first 2,500 participants of the COPDGene cohort were analyzed. Participant age was 61 ± 9 years; 51% were men; 76% were non-Hispanic Caucasians, and 24% were African Americans. Fifty-six percent had spirometrically defined COPD, with 9.3%, 23.4%, 15.0%, and 8.3% in GOLD (Global Initiative for Chronic Obstructive Lung Disease) stages I to IV, respectively. Higher % emphysema and % gas trapping predicted lower 6MWD (P < .001). However, in a given spirometric group, after adjustment for age, sex, race, and BMI, neither % emphysema nor % gas trapping, or their interactions with FEV(1) % predicted, remained a significant 6MWD predictor. In a given spirometric group, only 16% to 27% of the variance in 6MWD could be explained by age, male sex, Caucasian race, and lower BMI as significant predictors of higher 6MWD. CONCLUSIONS: In this large cohort of smokers in a given spirometric stage, phenotypic characteristics were only modestly predictive of 6MWD. CT scan measures of emphysema and gas trapping were not predictive of 6MWD after adjustment for other phenotypic characteristics.
BACKGROUND: Exercise tolerance in COPD is only moderately well predicted by airflow obstruction assessed by FEV(1). We determined whether other phenotypic characteristics, including CT scan measures, are independent predictors of 6-min walk distance (6MWD) in the COPDGene cohort. METHODS:COPDGene recruits non-Hispanic Caucasian and African American current and ex-smokers. Phenotyping measures include postbronchodilator FEV(1) % predicted and inspiratory and expiratory CT lung scans. We defined % emphysema as the percentage of lung voxels < -950 Hounsfield units on the inspiratory scan and % gas trapping as the percentage of lung voxels < -856 Hounsfield units on the expiratory scan. RESULTS: Data of the first 2,500 participants of the COPDGene cohort were analyzed. Participant age was 61 ± 9 years; 51% were men; 76% were non-Hispanic Caucasians, and 24% were African Americans. Fifty-six percent had spirometrically defined COPD, with 9.3%, 23.4%, 15.0%, and 8.3% in GOLD (Global Initiative for Chronic Obstructive Lung Disease) stages I to IV, respectively. Higher % emphysema and % gas trapping predicted lower 6MWD (P < .001). However, in a given spirometric group, after adjustment for age, sex, race, and BMI, neither % emphysema nor % gas trapping, or their interactions with FEV(1) % predicted, remained a significant 6MWD predictor. In a given spirometric group, only 16% to 27% of the variance in 6MWD could be explained by age, male sex, Caucasian race, and lower BMI as significant predictors of higher 6MWD. CONCLUSIONS: In this large cohort of smokers in a given spirometric stage, phenotypic characteristics were only modestly predictive of 6MWD. CT scan measures of emphysema and gas trapping were not predictive of 6MWD after adjustment for other phenotypic characteristics.
Authors: Alejandro A Diaz; Clarissa Valim; Tsuneo Yamashiro; Raúl San José Estépar; James C Ross; Shin Matsuoka; Brian Bartholmai; Hiroto Hatabu; Edwin K Silverman; George R Washko Journal: Chest Date: 2010-06-17 Impact factor: 9.410
Authors: P Boschetto; S Quintavalle; E Zeni; S Leprotti; A Potena; L Ballerin; A Papi; G Palladini; M Luisetti; L Annovazzi; P Iadarola; E De Rosa; L M Fabbri; C E Mapp Journal: Thorax Date: 2006-06-12 Impact factor: 9.139
Authors: T Troosters; J Vilaro; R Rabinovich; A Casas; J A Barberà; R Rodriguez-Roisin; J Roca Journal: Eur Respir J Date: 2002-09 Impact factor: 16.671
Authors: Woo Jin Kim; Edwin K Silverman; Eric Hoffman; Gerard J Criner; Zab Mosenifar; Frank C Sciurba; Barry J Make; Vincent Carey; Raúl San José Estépar; Alejandro Diaz; John J Reilly; Fernando J Martinez; George R Washko Journal: Chest Date: 2009-05-01 Impact factor: 9.410
Authors: William W Stringer; Janos Porszasz; Surya P Bhatt; Meredith C McCormack; Barry J Make; Richard Casaburi Journal: Chronic Obstr Pulm Dis Date: 2019-07-24
Authors: Nadia N Hansel; George R Washko; Marilyn G Foreman; MeiLan K Han; Eric A Hoffman; Dawn L DeMeo; R Graham Barr; Edwin J R Van Beek; Ella A Kazerooni; Robert A Wise; Robert H Brown; Jennifer Black-Shinn; John E Hokanson; Nicola A Hanania; Barry Make; Edwin K Silverman; James D Crapo; Mark T Dransfield Journal: COPD Date: 2013-02 Impact factor: 2.409
Authors: David M Macdonald; Elise F Palzer; Asghar Abbasi; Arianne K Baldomero; Surya P Bhatt; Richard Casaburi; John E Connett; Mark T Dransfield; Nathaniel T Gaeckle; Takudzwa Mkorombindo; Harry B Rossiter; William W Stringer; Nicholas B Tiller; Chris H Wendt; Dongxing Zhao; Ken M Kunisaki Journal: Respir Med Date: 2022-02-18 Impact factor: 3.415
Authors: Christian M Lo Cascio; Mirja Quante; Eric A Hoffman; Alain G Bertoni; Carrie P Aaron; Joseph E Schwartz; Mark V Avdalovic; Vincent S Fan; Gina S Lovasi; Steven M Kawut; John H M Austin; Susan Redline; R Graham Barr Journal: Chest Date: 2016-12-06 Impact factor: 9.410
Authors: Carina J Gronlund; Antonella Zanobetti; Gregory A Wellenius; Joel D Schwartz; Marie S O'Neill Journal: Clim Change Date: 2016-03-07 Impact factor: 4.743
Authors: Peter J Castaldi; Raúl San José Estépar; Carlos S Mendoza; Craig P Hersh; Nan Laird; James D Crapo; David A Lynch; Edwin K Silverman; George R Washko Journal: Am J Respir Crit Care Med Date: 2013-11-01 Impact factor: 21.405
Authors: Rola Harmouche; James C Ross; Alejandro A Diaz; George R Washko; Raul San Jose Estepar Journal: Acad Radiol Date: 2016-03-02 Impact factor: 3.173
Authors: Monica Campo; Krisann K Oursler; Laurence Huang; Matthew Bidwell Goetz; David Rimland; Guy Soo Hoo; Sheldon T Brown; Maria C Rodriguez-Barradas; David Au; Kathleen M Akgün; Shahida Shahrir; Kristina Crothers Journal: J Acquir Immune Defic Syndr Date: 2014-04-15 Impact factor: 3.731
Authors: Bhavinkumar B Patel; Carlos A Barrero; Alan Braverman; Phillip D Kim; Kelly A Jones; Dian Er Chen; Russell P Bowler; Salim Merali; Steven G Kelsen; Anthony T Yeung Journal: J Proteome Res Date: 2012-10-29 Impact factor: 4.466